Compounds > ibogaine
Page last updated: 2024-09-05

ibogaine and Arrhythmia

ibogaine has been researched along with Arrhythmia in 8 studies

Research

Studies (8)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's7 (87.50)24.3611
2020's1 (12.50)2.80

Authors

AuthorsStudies
Gerona, R; Grogan, J; Kao, L; Snow, JW1
Anderson, EI; Brown, BM; Cameron, LP; Dunlap, LE; Ehinger, Y; Fiehn, O; Hurley, ZQ; Kokel, D; Laskowski, LJ; Lein, PJ; Liu, T; Lu, J; McCarroll, MN; McCorvy, JD; Myers-Turnbull, D; Olson, DE; Pell, AJ; Peters, J; Rabow, ZT; Ron, D; Taylor, JC; Tjia, M; Tombari, RJ; Vargas, MV; Viswanathan, J; Wulff, H; Yaghoobi, B; Zhang, G; Zuo, Y1
Deng, JF; Yip, L1
Asua, I1
Boehm, S; Eckert, D; Hilber, K; Koenig, X; Rubi, L1
Galea, S; Newcombe, D; Schep, LJ; Slaughter, RJ1
Nestor, J1
Boehm, S; Hilber, K; Koenig, X; Kovar, M; Sandtner, W1

Reviews

1 review(s) available for ibogaine and Arrhythmia

ArticleYear
Ibogaine for treating drug dependence. What is a safe dose?
    Drug and alcohol dependence, 2016, Sep-01, Volume: 166

    Topics: Animals; Arrhythmias, Cardiac; Dose-Response Relationship, Drug; Hallucinogens; Humans; Ibogaine; Substance-Related Disorders; Treatment Outcome

2016

Other Studies

7 other study(ies) available for ibogaine and Arrhythmia

ArticleYear
Ibogaine Consumption With Seizure-Like Episodes, QTc-Prolongation, and Captured Cardiac Dysrhythmias.
    The Journal of emergency medicine, 2019, Volume: 57, Issue:4

    Topics: Adult; Arrhythmias, Cardiac; Excitatory Amino Acid Antagonists; Female; Heroin Dependence; Humans; Ibogaine; Long QT Syndrome; Seizures; Tabernaemontana

2019
A non-hallucinogenic psychedelic analogue with therapeutic potential.
    Nature, 2021, Volume: 589, Issue:7842

    Topics: Alcoholism; Animals; Antidepressive Agents; Arrhythmias, Cardiac; Behavior, Addictive; Chemistry Techniques, Synthetic; Depression; Disease Models, Animal; Drug Design; Female; Hallucinogens; Heroin Dependence; Ibogaine; Male; Mice; Mice, Inbred C57BL; Neuronal Plasticity; Patient Safety; Receptor, Serotonin, 5-HT2A; Serotonin 5-HT2 Receptor Agonists; Substance-Related Disorders; Swimming; Tabernaemontana

2021
On the relationship between ibogaine and noribogaine.
    Clinical toxicology (Philadelphia, Pa.), 2018, Volume: 56, Issue:1

    Topics: Arrhythmias, Cardiac; Humans; Ibogaine; Internet; Toxicokinetics

2018
Growing menace of ibogaine toxicity.
    British journal of anaesthesia, 2013, Volume: 111, Issue:6

    Topics: Arrhythmias, Cardiac; Excitatory Amino Acid Antagonists; Heroin; Humans; Ibogaine; Male; Narcotics; Self Medication; Substance Withdrawal Syndrome; Young Adult

2013
Anti-addiction Drug Ibogaine Prolongs the Action Potential in Human Induced Pluripotent Stem Cell-Derived Cardiomyocytes.
    Cardiovascular toxicology, 2017, Volume: 17, Issue:2

    Topics: Action Potentials; Arrhythmias, Cardiac; Cell Differentiation; Cells, Cultured; Dose-Response Relationship, Drug; Heart Rate; Humans; Ibogaine; Induced Pluripotent Stem Cells; Myocytes, Cardiac; Neurotransmitter Agents; Patch-Clamp Techniques; Risk Assessment; Substance-Related Disorders; Time Factors

2017
Get Clean or Die Trying.
    Scientific American, 2016, Oct-18, Volume: 315, Issue:5

    Topics: Acetylcholine; Arrhythmias, Cardiac; Brain; Dopamine; Excitatory Amino Acid Antagonists; Female; Hallucinogens; Heart Arrest; Heroin Dependence; Humans; Ibogaine; Male; Serotonin; Substance-Related Disorders

2016
Anti-addiction drug ibogaine inhibits hERG channels: a cardiac arrhythmia risk.
    Addiction biology, 2014, Volume: 19, Issue:2

    Topics: Adult; Animals; Arrhythmias, Cardiac; Behavior, Addictive; Dose-Response Relationship, Drug; Ether-A-Go-Go Potassium Channels; Excitatory Amino Acid Antagonists; Female; Heart Rate; Humans; Ibogaine; Secondary Prevention

2014